Glaukos Obtains $30,000,000 Series F Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    26051 Merit Circle Laguna Hills, CA 92653
  • Company Description
    Glaukos is creating a new class of micro-bypass therapies to achieve sustainable, target intraocular pressures through the restoration of physiologic outflow, reduce the challenges and risks of glaucoma management associated with traditional therapies, and aid in the preservation of vision.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series F
  • Proceeds Purposes
    The funds also will be used for investigational device exemption pivotal registration studies of iStent supra, a suprachoroidal implant, and iStent inject, a second-generation trabecular bypass implant.
  • M&A Terms
  • Venture Investor
    Meritech Capital Partners
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Montreux Equity Partners
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    OrbiMed Advisors
  • Venture Investor
    Gund Investment Corporation
  • Venture Investor
    Domain Associates

Trending on Xconomy